APO Research
Talk to an analyst

APO RESEARCH · REPORT

Vandetanib Tablets

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Vandetanib Tablets Industry Growth and Trends Forecast to 2032

27 December 202576 pages

Choose your research edition.

Industry ResearchVandetanib Tablets Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal Vandetanib Tablets Industry Growth and Trends Forecast to 203276 pages · $3,450 USDMarket StructureGlobal Vandetanib Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032171 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vandetanib Tablets Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Vandetanib Tablets Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Vandetanib Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Vandetanib Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Vandetanib Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Vandetanib Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Vandetanib Tablets include Lucius Pharma, AstraZeneca and Sanofi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Vandetanib Tablets market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Vandetanib Tablets market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Vandetanib Tablets market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Vandetanib Tablets.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Vandetanib Tablets market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Vandetanib Tablets Market by Company

Lucius Pharma

AstraZeneca

Sanofi

Vandetanib Tablets Segment by Type

100mg per Tablet

300mg per Tablet

Vandetanib Tablets Segment by Application

Hospital and Clinic

Retail Pharmacies

Other

Vandetanib Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vandetanib Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vandetanib Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vandetanib Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Vandetanib Tablets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Vandetanib Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 100mg per Tablet Table 2. Major Company of 300mg per Tablet Table 3. Global Vandetanib Tablets Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Vandetanib Tablets Sales by Type (2021-2026) & (K Units) Table 5. Global Vandetanib Tablets Sales Market Share in Volume by Type (2021-2026) Table 6. Global Vandetanib Tablets Sales by Type (2021-2026) & (US$ Million) Table 7. Global Vandetanib Tablets Sales Market Share in Value by Type (2021-2026) Table 8. Global Vandetanib Tablets Price by Type (2021-2026) & (US$/Unit) Table 9. Global Vandetanib Tablets Sales by Type (2027-2032) & (K Units) Table 10. Global Vandetanib Tablets Sales Market Share in Volume by Type (2027-2032) Table 11. Global Vandetanib Tablets Sales by Type (2027-2032) & (US$ Million) Table 12. Global Vandetanib Tablets Sales Market Share in Value by Type (2027-2032) Table 13. Global Vandetanib Tablets Price by Type (2027-2032) & (US$/Unit) Table 14. North America Vandetanib Tablets Sales by Type (2021-2026) & (K Units) Table 15. North America Vandetanib Tablets Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Vandetanib Tablets Sales by Type (2021-2026) & (K Units) Table 17. Europe Vandetanib Tablets Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Vandetanib Tablets Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Vandetanib Tablets Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Vandetanib Tablets Sales by Type (2021-2026) & (K Units) Table 21. Latin America Vandetanib Tablets Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Vandetanib Tablets Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Vandetanib Tablets Sales by Type (2021-2026) & (US$ Million) Table 24. Vandetanib Tablets Industry Trends Table 25. Vandetanib Tablets Industry Drivers Table 26. Vandetanib Tablets Industry Opportunities and Challenges Table 27. Vandetanib Tablets Industry Restraints Table 28. Global Vandetanib Tablets Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Vandetanib Tablets Revenue Market Share by Company (2021-2026) Table 30. Global Vandetanib Tablets Sales by Company (2021-2026) & (K Units) Table 31. Global Vandetanib Tablets Sales Share by Company (2021-2026) Table 32. Global Vandetanib Tablets Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Vandetanib Tablets Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Vandetanib Tablets Major Company Production Sites and Headquarters Table 35. Global Vandetanib Tablets Company, Product Type & Application Table 36. Global Vandetanib Tablets Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Vandetanib Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Vandetanib Tablets Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Vandetanib Tablets Sales by Region (2021-2026) & (K Units) Table 41. Global Vandetanib Tablets Sales Market Share in Volume by Region (2021-2026) Table 42. Global Vandetanib Tablets Sales by Region (2021-2026) & (US$ Million) Table 43. Global Vandetanib Tablets Sales Market Share in Value by Region (2021-2026) Table 44. Global Vandetanib Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Vandetanib Tablets Sales by Region (2027-2032) & (K Units) Table 46. Global Vandetanib Tablets Sales Market Share in Volume by Region (2027-2032) Table 47. Global Vandetanib Tablets Sales by Region (2027-2032) & (US$ Million) Table 48. Global Vandetanib Tablets Sales Market Share in Value by Region (2027-2032) Table 49. Global Vandetanib Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Vandetanib Tablets Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Vandetanib Tablets Sales by Application (2021-2026) & (K Units) Table 52. Global Vandetanib Tablets Sales Market Share in Volume by Application (2021-2026) Table 53. Global Vandetanib Tablets Sales by Application (2021-2026) & (US$ Million) Table 54. Global Vandetanib Tablets Sales Market Share in Value by Application (2021-2026) Table 55. Global Vandetanib Tablets Price by Application (2021-2026) & (US$/Unit) Table 56. Global Vandetanib Tablets Sales by Application (2027-2032) & (K Units) Table 57. Global Vandetanib Tablets Sales Market Share in Volume by Application (2027-2032) Table 58. Global Vandetanib Tablets Sales by Application (2027-2032) & (US$ Million) Table 59. Global Vandetanib Tablets Sales Market Share in Value by Application (2027-2032) Table 60. Global Vandetanib Tablets Price by Application (2027-2032) & (US$/Unit) Table 61. North America Vandetanib Tablets Sales by Application (2021-2026) & (K Units) Table 62. North America Vandetanib Tablets Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Vandetanib Tablets Sales by Application (2021-2026) & (K Units) Table 64. Europe Vandetanib Tablets Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Vandetanib Tablets Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Vandetanib Tablets Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Vandetanib Tablets Sales by Application (2021-2026) & (K Units) Table 68. Latin America Vandetanib Tablets Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Vandetanib Tablets Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Vandetanib Tablets Sales by Application (2021-2026) & (US$ Million) Table 71. Lucius Pharma Company Information Table 72. Lucius Pharma Business Overview Table 73. Lucius Pharma Vandetanib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Lucius Pharma Vandetanib Tablets Product Portfolio Table 75. Lucius Pharma Recent Development Table 76. AstraZeneca Company Information Table 77. AstraZeneca Business Overview Table 78. AstraZeneca Vandetanib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. AstraZeneca Vandetanib Tablets Product Portfolio Table 80. AstraZeneca Recent Development Table 81. Sanofi Company Information Table 82. Sanofi Business Overview Table 83. Sanofi Vandetanib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Sanofi Vandetanib Tablets Product Portfolio Table 85. Sanofi Recent Development Table 86. North America Vandetanib Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 87. North America Vandetanib Tablets Sales by Country (2021-2026) & (K Units) Table 88. North America Vandetanib Tablets Sales Market Share by Country (2021-2026) Table 89. North America Vandetanib Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 90. North America Vandetanib Tablets Sales Market Share Forecast by Country (2027-2032) Table 91. North America Vandetanib Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 92. North America Vandetanib Tablets Market Size by Country (2021-2026) & (US$ Million) Table 93. North America Vandetanib Tablets Market Share by Country (2021-2026) Table 94. North America Vandetanib Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 95. North America Vandetanib Tablets Market Share Forecast by Country (2027-2032) Table 96. Europe Vandetanib Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 97. Europe Vandetanib Tablets Sales by Country (2021-2026) & (K Units) Table 98. Europe Vandetanib Tablets Sales Market Share by Country (2021-2026) Table 99. Europe Vandetanib Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 100. Europe Vandetanib Tablets Sales Market Share Forecast by Country (2027-2032) Table 101. Europe Vandetanib Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. Europe Vandetanib Tablets Market Size by Country (2021-2026) & (US$ Million) Table 103. Europe Vandetanib Tablets Market Share by Country (2021-2026) Table 104. Europe Vandetanib Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. Europe Vandetanib Tablets Market Share Forecast by Country (2027-2032) Table 106. Asia-Pacific Vandetanib Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 107. Asia-Pacific Vandetanib Tablets Sales by Country (2021-2026) & (K Units) Table 108. Asia-Pacific Vandetanib Tablets Sales Market Share by Country (2021-2026) Table 109. Asia-Pacific Vandetanib Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 110. Asia-Pacific Vandetanib Tablets Sales Market Share Forecast by Country (2027-2032) Table 111. Asia-Pacific Vandetanib Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Asia-Pacific Vandetanib Tablets Market Size by Country (2021-2026) & (US$ Million) Table 113. Asia-Pacific Vandetanib Tablets Market Share by Country (2021-2026) Table 114. Asia-Pacific Vandetanib Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Asia-Pacific Vandetanib Tablets Market Share Forecast by Country (2027-2032) Table 116. Latin America Vandetanib Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 117. Latin America Vandetanib Tablets Sales by Country (2021-2026) & (K Units) Table 118. Latin America Vandetanib Tablets Sales Market Share by Country (2021-2026) Table 119. Latin America Vandetanib Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 120. Latin America Vandetanib Tablets Sales Market Share Forecast by Country (2027-2032) Table 121. Latin America Vandetanib Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Latin America Vandetanib Tablets Market Size by Country (2021-2026) & (US$ Million) Table 123. Latin America Vandetanib Tablets Market Share by Country (2021-2026) Table 124. Latin America Vandetanib Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Latin America Vandetanib Tablets Market Share Forecast by Country (2027-2032) Table 126. Middle East and Africa Vandetanib Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. Middle East and Africa Vandetanib Tablets Sales by Country (2021-2026) & (K Units) Table 128. Middle East and Africa Vandetanib Tablets Sales Market Share by Country (2021-2026) Table 129. Middle East and Africa Vandetanib Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 130. Middle East and Africa Vandetanib Tablets Sales Market Share Forecast by Country (2027-2032) Table 131. Middle East and Africa Vandetanib Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Middle East and Africa Vandetanib Tablets Market Size by Country (2021-2026) & (US$ Million) Table 133. Middle East and Africa Vandetanib Tablets Market Share by Country (2021-2026) Table 134. Middle East and Africa Vandetanib Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Middle East and Africa Vandetanib Tablets Market Share Forecast by Country (2027-2032) Table 136. Key Raw Materials Table 137. Raw Materials Key Suppliers Table 138. Vandetanib Tablets Distributors List Table 139. Vandetanib Tablets Customers List Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. Vandetanib Tablets Image Figure 2. Global Vandetanib Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Vandetanib Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Vandetanib Tablets Sales (2021-2032) & (K Units) Figure 5. 100mg per Tablet Image Figure 6. Global 100mg per Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 7. 300mg per Tablet Image Figure 8. Global 300mg per Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Vandetanib Tablets Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Vandetanib Tablets Market Share by Type 2025 VS 2032 Figure 11. North America Vandetanib Tablets Sales Market Share in Volume by Type in 2025 Figure 12. North America Vandetanib Tablets Sales Market Share in Value by Type in 2025 Figure 13. Europe Vandetanib Tablets Sales Market Share in Volume by Type in 2025 Figure 14. Europe Vandetanib Tablets Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Vandetanib Tablets Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Vandetanib Tablets Sales Market Share in Value by Type in 2025 Figure 17. Latin America Vandetanib Tablets Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Vandetanib Tablets Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Vandetanib Tablets Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Vandetanib Tablets Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Vandetanib Tablets Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital and Clinic Image Figure 24. Global Hospital and Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 25. Retail Pharmacies Image Figure 26. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Vandetanib Tablets Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Vandetanib Tablets Market Share by Application 2025 VS 2032 Figure 31. North America Vandetanib Tablets Sales Market Share in Volume by Application in 2025 Figure 32. North America Vandetanib Tablets Sales Market Share in Value by Application in 2025 Figure 33. Europe Vandetanib Tablets Sales Market Share in Volume by Application in 2025 Figure 34. Europe Vandetanib Tablets Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Vandetanib Tablets Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Vandetanib Tablets Sales Market Share in Value by Application in 2025 Figure 37. Latin America Vandetanib Tablets Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Vandetanib Tablets Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Vandetanib Tablets Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Vandetanib Tablets Sales Market Share in Value by Application in 2025 Figure 41. North America Vandetanib Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Vandetanib Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Vandetanib Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Vandetanib Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Vandetanib Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Vandetanib Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Vandetanib Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Vandetanib Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Vandetanib Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Vandetanib Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Vandetanib Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Vandetanib Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Vandetanib Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Vandetanib Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Vandetanib Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Vandetanib Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Vandetanib Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Vandetanib Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Vandetanib Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Vandetanib Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Vandetanib Tablets Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Vandetanib Tablets Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 100mg per Tablet
  • 300mg per Tablet
Applications
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
Companies covered
  • Lucius Pharma
  • AstraZeneca
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Vandetanib Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Vandetanib Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Vandetanib Tablets Market by Type
  6. 1.3.1 100mg per Tablet
  7. 1.3.2 300mg per Tablet
  8. 1.4 Global Vandetanib Tablets Market Size by Type
  9. 1.4.1 Global Vandetanib Tablets Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Vandetanib Tablets Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Vandetanib Tablets Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Vandetanib Tablets Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Vandetanib Tablets Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Vandetanib Tablets Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Vandetanib Tablets Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Vandetanib Tablets Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Vandetanib Tablets Industry Trends
  2. 2.2 Vandetanib Tablets Industry Drivers
  3. 2.3 Vandetanib Tablets Industry Opportunities and Challenges
  4. 2.4 Vandetanib Tablets Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Vandetanib Tablets Revenue (2021-2026)
  2. 3.2 Global Top Players by Vandetanib Tablets Sales (2021-2026)
  3. 3.3 Global Top Players by Vandetanib Tablets Price (2021-2026)
  4. 3.4 Global Vandetanib Tablets Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Vandetanib Tablets Major Company Production Sites & Headquarters
  6. 3.6 Global Vandetanib Tablets Company, Product Type & Application
  7. 3.7 Global Vandetanib Tablets Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Vandetanib Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Vandetanib Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Vandetanib Tablets Tier 1, Tier 2, and Tier 3
4 Vandetanib Tablets Regional Status and Outlook
  1. 4.1 Global Vandetanib Tablets Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Vandetanib Tablets Historic Market Size by Region
  3. 4.2.1 Global Vandetanib Tablets Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Vandetanib Tablets Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Vandetanib Tablets Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Vandetanib Tablets Forecasted Market Size by Region
  7. 4.3.1 Global Vandetanib Tablets Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Vandetanib Tablets Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Vandetanib Tablets Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Vandetanib Tablets by Application
  1. 5.1 Vandetanib Tablets Market by Application
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Retail Pharmacies
  4. 5.1.3 Other
  5. 5.2 Global Vandetanib Tablets Market Size by Application
  6. 5.2.1 Global Vandetanib Tablets Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Vandetanib Tablets Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Vandetanib Tablets Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Vandetanib Tablets Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Vandetanib Tablets Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Vandetanib Tablets Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Vandetanib Tablets Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Vandetanib Tablets Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Lucius Pharma
  2. 6.1.1 Lucius Pharma Company Information
  3. 6.1.2 Lucius Pharma Business Overview
  4. 6.1.3 Lucius Pharma Vandetanib Tablets Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Lucius Pharma Vandetanib Tablets Product Portfolio
  6. 6.1.5 Lucius Pharma Recent Developments
  7. 6.2 AstraZeneca
  8. 6.2.1 AstraZeneca Company Information
  9. 6.2.2 AstraZeneca Business Overview
  10. 6.2.3 AstraZeneca Vandetanib Tablets Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 AstraZeneca Vandetanib Tablets Product Portfolio
  12. 6.2.5 AstraZeneca Recent Developments
  13. 6.3 Sanofi
  14. 6.3.1 Sanofi Company Information
  15. 6.3.2 Sanofi Business Overview
  16. 6.3.3 Sanofi Vandetanib Tablets Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sanofi Vandetanib Tablets Product Portfolio
  18. 6.3.5 Sanofi Recent Developments
7 North America by Country
  1. 7.1 North America Vandetanib Tablets Sales by Country
  2. 7.1.1 North America Vandetanib Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Vandetanib Tablets Sales by Country (2021-2026)
  4. 7.1.3 North America Vandetanib Tablets Sales Forecast by Country (2027-2032)
  5. 7.2 North America Vandetanib Tablets Market Size by Country
  6. 7.2.1 North America Vandetanib Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Vandetanib Tablets Market Size by Country (2021-2026)
  8. 7.2.3 North America Vandetanib Tablets Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Vandetanib Tablets Sales by Country
  2. 8.1.1 Europe Vandetanib Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Vandetanib Tablets Sales by Country (2021-2026)
  4. 8.1.3 Europe Vandetanib Tablets Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Vandetanib Tablets Market Size by Country
  6. 8.2.1 Europe Vandetanib Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Vandetanib Tablets Market Size by Country (2021-2026)
  8. 8.2.3 Europe Vandetanib Tablets Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Vandetanib Tablets Sales by Country
  2. 9.1.1 Asia-Pacific Vandetanib Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Vandetanib Tablets Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Vandetanib Tablets Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Vandetanib Tablets Market Size by Country
  6. 9.2.1 Asia-Pacific Vandetanib Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Vandetanib Tablets Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Vandetanib Tablets Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Vandetanib Tablets Sales by Country
  2. 10.1.1 South America Vandetanib Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Vandetanib Tablets Sales by Country (2021-2026)
  4. 10.1.3 South America Vandetanib Tablets Sales Forecast by Country (2027-2032)
  5. 10.2 South America Vandetanib Tablets Market Size by Country
  6. 10.2.1 South America Vandetanib Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Vandetanib Tablets Market Size by Country (2021-2026)
  8. 10.2.3 South America Vandetanib Tablets Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Vandetanib Tablets Sales by Country
  2. 11.1.1 Middle East and Africa Vandetanib Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Vandetanib Tablets Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Vandetanib Tablets Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Vandetanib Tablets Market Size by Country
  6. 11.2.1 Middle East and Africa Vandetanib Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Vandetanib Tablets Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Vandetanib Tablets Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Vandetanib Tablets Value Chain Analysis
  2. 12.1.1 Vandetanib Tablets Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Vandetanib Tablets Production Mode & Process
  7. 12.2 Vandetanib Tablets Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Vandetanib Tablets Distributors
  10. 12.2.3 Vandetanib Tablets Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst